世界の診断用核医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diagnostic Nuclear Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5703
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、診断用核医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Tc-99m、F-18、その他）、用途別市場規模（腫瘍学、心臓病学、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・診断用核医薬品の市場動向
・企業の競争状況、市場シェア
・診断用核医薬品の種類別市場規模と予測2016-2027（Tc-99m、F-18、その他）
・診断用核医薬品の用途別市場規模と予測2016-2027（腫瘍学、心臓病学、その他）
・診断用核医薬品の北米市場規模2016-2027（アメリカ、カナダ）
・診断用核医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・診断用核医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・診断用核医薬品の中南米市場規模2016-2027（メキシコ、ブラジル）
・診断用核医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bracco Imaging、Bayer、Curium Pharmaceuticals、Nordion、Triad Isotopes、Lantheus、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Novartis、SIEMENS、Dongcheng、Navidea）
・結論

Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis

Market Analysis and Insights: Global Diagnostic Nuclear Drug Market
The global Diagnostic Nuclear Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diagnostic Nuclear Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diagnostic Nuclear Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diagnostic Nuclear Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diagnostic Nuclear Drug market.

Global Diagnostic Nuclear Drug Scope and Market Size
Diagnostic Nuclear Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Nuclear Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tc-99m
F-18
Other

Segment by Application
Oncology
Cardiology
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tc-99m
1.2.3 F-18
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diagnostic Nuclear Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diagnostic Nuclear Drug Market Perspective (2016-2027)
2.2 Diagnostic Nuclear Drug Growth Trends by Regions
2.2.1 Diagnostic Nuclear Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diagnostic Nuclear Drug Historic Market Share by Regions (2016-2021)
2.2.3 Diagnostic Nuclear Drug Forecasted Market Size by Regions (2022-2027)
2.3 Diagnostic Nuclear Drug Industry Dynamic
2.3.1 Diagnostic Nuclear Drug Market Trends
2.3.2 Diagnostic Nuclear Drug Market Drivers
2.3.3 Diagnostic Nuclear Drug Market Challenges
2.3.4 Diagnostic Nuclear Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Nuclear Drug Players by Revenue
3.1.1 Global Top Diagnostic Nuclear Drug Players by Revenue (2016-2021)
3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2016-2021)
3.2 Global Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Nuclear Drug Revenue
3.4 Global Diagnostic Nuclear Drug Market Concentration Ratio
3.4.1 Global Diagnostic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Drug Revenue in 2020
3.5 Diagnostic Nuclear Drug Key Players Head office and Area Served
3.6 Key Players Diagnostic Nuclear Drug Product Solution and Service
3.7 Date of Enter into Diagnostic Nuclear Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Nuclear Drug Breakdown Data by Type
4.1 Global Diagnostic Nuclear Drug Historic Market Size by Type (2016-2021)
4.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2022-2027)

5 Diagnostic Nuclear Drug Breakdown Data by Application
5.1 Global Diagnostic Nuclear Drug Historic Market Size by Application (2016-2021)
5.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diagnostic Nuclear Drug Market Size (2016-2027)
6.2 North America Diagnostic Nuclear Drug Market Size by Type
6.2.1 North America Diagnostic Nuclear Drug Market Size by Type (2016-2021)
6.2.2 North America Diagnostic Nuclear Drug Market Size by Type (2022-2027)
6.2.3 North America Diagnostic Nuclear Drug Market Size by Type (2016-2027)
6.3 North America Diagnostic Nuclear Drug Market Size by Application
6.3.1 North America Diagnostic Nuclear Drug Market Size by Application (2016-2021)
6.3.2 North America Diagnostic Nuclear Drug Market Size by Application (2022-2027)
6.3.3 North America Diagnostic Nuclear Drug Market Size by Application (2016-2027)
6.4 North America Diagnostic Nuclear Drug Market Size by Country
6.4.1 North America Diagnostic Nuclear Drug Market Size by Country (2016-2021)
6.4.2 North America Diagnostic Nuclear Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Diagnostic Nuclear Drug Market Size (2016-2027)
7.2 Europe Diagnostic Nuclear Drug Market Size by Type
7.2.1 Europe Diagnostic Nuclear Drug Market Size by Type (2016-2021)
7.2.2 Europe Diagnostic Nuclear Drug Market Size by Type (2022-2027)
7.2.3 Europe Diagnostic Nuclear Drug Market Size by Type (2016-2027)
7.3 Europe Diagnostic Nuclear Drug Market Size by Application
7.3.1 Europe Diagnostic Nuclear Drug Market Size by Application (2016-2021)
7.3.2 Europe Diagnostic Nuclear Drug Market Size by Application (2022-2027)
7.3.3 Europe Diagnostic Nuclear Drug Market Size by Application (2016-2027)
7.4 Europe Diagnostic Nuclear Drug Market Size by Country
7.4.1 Europe Diagnostic Nuclear Drug Market Size by Country (2016-2021)
7.4.2 Europe Diagnostic Nuclear Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Nuclear Drug Market Size (2016-2027)
8.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type
8.2.1 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application
8.3.1 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region
8.4.1 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diagnostic Nuclear Drug Market Size (2016-2027)
9.2 Latin America Diagnostic Nuclear Drug Market Size by Type
9.2.1 Latin America Diagnostic Nuclear Drug Market Size by Type (2016-2021)
9.2.2 Latin America Diagnostic Nuclear Drug Market Size by Type (2022-2027)
9.2.3 Latin America Diagnostic Nuclear Drug Market Size by Type (2016-2027)
9.3 Latin America Diagnostic Nuclear Drug Market Size by Application
9.3.1 Latin America Diagnostic Nuclear Drug Market Size by Application (2016-2021)
9.3.2 Latin America Diagnostic Nuclear Drug Market Size by Application (2022-2027)
9.3.3 Latin America Diagnostic Nuclear Drug Market Size by Application (2016-2027)
9.4 Latin America Diagnostic Nuclear Drug Market Size by Country
9.4.1 Latin America Diagnostic Nuclear Drug Market Size by Country (2016-2021)
9.4.2 Latin America Diagnostic Nuclear Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Nuclear Drug Market Size (2016-2027)
10.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type
10.2.1 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application
10.3.1 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country
10.4.1 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Details
11.1.2 Bracco Imaging Business Overview
11.1.3 Bracco Imaging Diagnostic Nuclear Drug Introduction
11.1.4 Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.1.5 Bracco Imaging Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Diagnostic Nuclear Drug Introduction
11.2.4 Bayer Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Curium Pharmaceuticals
11.3.1 Curium Pharmaceuticals Company Details
11.3.2 Curium Pharmaceuticals Business Overview
11.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Introduction
11.3.4 Curium Pharmaceuticals Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.3.5 Curium Pharmaceuticals Recent Development
11.4 Nordion
11.4.1 Nordion Company Details
11.4.2 Nordion Business Overview
11.4.3 Nordion Diagnostic Nuclear Drug Introduction
11.4.4 Nordion Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.4.5 Nordion Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Details
11.5.2 Triad Isotopes Business Overview
11.5.3 Triad Isotopes Diagnostic Nuclear Drug Introduction
11.5.4 Triad Isotopes Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.5.5 Triad Isotopes Recent Development
11.6 Lantheus
11.6.1 Lantheus Company Details
11.6.2 Lantheus Business Overview
11.6.3 Lantheus Diagnostic Nuclear Drug Introduction
11.6.4 Lantheus Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.6.5 Lantheus Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Diagnostic Nuclear Drug Introduction
11.7.4 GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.7.5 GE Healthcare Recent Development
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Details
11.8.2 China Isotope & Radiation Business Overview
11.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Introduction
11.8.4 China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.8.5 China Isotope & Radiation Recent Development
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Details
11.9.2 Jubilant Pharma Business Overview
11.9.3 Jubilant Pharma Diagnostic Nuclear Drug Introduction
11.9.4 Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.9.5 Jubilant Pharma Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Diagnostic Nuclear Drug Introduction
11.10.4 Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Diagnostic Nuclear Drug Introduction
11.11.4 Novartis Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.11.5 Novartis Recent Development
11.12 SIEMENS
11.12.1 SIEMENS Company Details
11.12.2 SIEMENS Business Overview
11.12.3 SIEMENS Diagnostic Nuclear Drug Introduction
11.12.4 SIEMENS Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.12.5 SIEMENS Recent Development
11.13 Dongcheng
11.13.1 Dongcheng Company Details
11.13.2 Dongcheng Business Overview
11.13.3 Dongcheng Diagnostic Nuclear Drug Introduction
11.13.4 Dongcheng Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.13.5 Dongcheng Recent Development
11.14 Navidea
11.14.1 Navidea Company Details
11.14.2 Navidea Business Overview
11.14.3 Navidea Diagnostic Nuclear Drug Introduction
11.14.4 Navidea Revenue in Diagnostic Nuclear Drug Business (2016-2021)
11.14.5 Navidea Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diagnostic Nuclear Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tc-99m
Table 3. Key Players of F-18
Table 4. Key Players of Other
Table 5. Global Diagnostic Nuclear Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diagnostic Nuclear Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diagnostic Nuclear Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Diagnostic Nuclear Drug Market Share by Regions (2016-2021)
Table 9. Global Diagnostic Nuclear Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Diagnostic Nuclear Drug Market Share by Regions (2022-2027)
Table 11. Diagnostic Nuclear Drug Market Trends
Table 12. Diagnostic Nuclear Drug Market Drivers
Table 13. Diagnostic Nuclear Drug Market Challenges
Table 14. Diagnostic Nuclear Drug Market Restraints
Table 15. Global Diagnostic Nuclear Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Diagnostic Nuclear Drug Market Share by Players (2016-2021)
Table 17. Global Top Diagnostic Nuclear Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Nuclear Drug as of 2020)
Table 18. Ranking of Global Top Diagnostic Nuclear Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Diagnostic Nuclear Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diagnostic Nuclear Drug Product Solution and Service
Table 22. Date of Enter into Diagnostic Nuclear Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Diagnostic Nuclear Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Diagnostic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Diagnostic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Diagnostic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Diagnostic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Diagnostic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Diagnostic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bracco Imaging Company Details
Table 63. Bracco Imaging Business Overview
Table 64. Bracco Imaging Diagnostic Nuclear Drug Product
Table 65. Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 66. Bracco Imaging Recent Development
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Diagnostic Nuclear Drug Product
Table 70. Bayer Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 71. Bayer Recent Development
Table 72. Curium Pharmaceuticals Company Details
Table 73. Curium Pharmaceuticals Business Overview
Table 74. Curium Pharmaceuticals Diagnostic Nuclear Drug Product
Table 75. Curium Pharmaceuticals Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 76. Curium Pharmaceuticals Recent Development
Table 77. Nordion Company Details
Table 78. Nordion Business Overview
Table 79. Nordion Diagnostic Nuclear Drug Product
Table 80. Nordion Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 81. Nordion Recent Development
Table 82. Triad Isotopes Company Details
Table 83. Triad Isotopes Business Overview
Table 84. Triad Isotopes Diagnostic Nuclear Drug Product
Table 85. Triad Isotopes Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 86. Triad Isotopes Recent Development
Table 87. Lantheus Company Details
Table 88. Lantheus Business Overview
Table 89. Lantheus Diagnostic Nuclear Drug Product
Table 90. Lantheus Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 91. Lantheus Recent Development
Table 92. GE Healthcare Company Details
Table 93. GE Healthcare Business Overview
Table 94. GE Healthcare Diagnostic Nuclear Drug Product
Table 95. GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 96. GE Healthcare Recent Development
Table 97. China Isotope & Radiation Company Details
Table 98. China Isotope & Radiation Business Overview
Table 99. China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 100. China Isotope & Radiation Recent Development
Table 101. Jubilant Pharma Company Details
Table 102. Jubilant Pharma Business Overview
Table 103. Jubilant Pharma Diagnostic Nuclear Drug Product
Table 104. Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 105. Jubilant Pharma Recent Development
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Diagnostic Nuclear Drug Product
Table 109. Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Novartis Company Details
Table 112. Novartis Business Overview
Table 113. Novartis Diagnostic Nuclear Drug Product
Table 114. Novartis Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 115. Novartis Recent Development
Table 116. SIEMENS Company Details
Table 117. SIEMENS Business Overview
Table 118. SIEMENS Diagnostic Nuclear Drug Product
Table 119. SIEMENS Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 120. SIEMENS Recent Development
Table 121. Dongcheng Company Details
Table 122. Dongcheng Business Overview
Table 123. Dongcheng Diagnostic Nuclear Drug Product
Table 124. Dongcheng Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 125. Dongcheng Recent Development
Table 126. Navidea Company Details
Table 127. Navidea Business Overview
Table 128. Navidea Diagnostic Nuclear Drug Product
Table 129. Navidea Revenue in Diagnostic Nuclear Drug Business (2016-2021) & (US$ Million)
Table 130. Navidea Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Nuclear Drug Market Share by Type: 2020 VS 2027
Figure 2. Tc-99m Features
Figure 3. F-18 Features
Figure 4. Other Features
Figure 5. Global Diagnostic Nuclear Drug Market Share by Application: 2020 VS 2027
Figure 6. Oncology Case Studies
Figure 7. Cardiology Case Studies
Figure 8. Other Case Studies
Figure 9. Diagnostic Nuclear Drug Report Years Considered
Figure 10. Global Diagnostic Nuclear Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Diagnostic Nuclear Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Diagnostic Nuclear Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Diagnostic Nuclear Drug Market Share by Regions (2022-2027)
Figure 14. Global Diagnostic Nuclear Drug Market Share by Players in 2020
Figure 15. Global Top Diagnostic Nuclear Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Nuclear Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Diagnostic Nuclear Drug Revenue in 2020
Figure 17. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Diagnostic Nuclear Drug Market Share by Type (2016-2027)
Figure 21. North America Diagnostic Nuclear Drug Market Share by Application (2016-2027)
Figure 22. North America Diagnostic Nuclear Drug Market Share by Country (2016-2027)
Figure 23. United States Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diagnostic Nuclear Drug Market Share by Type (2016-2027)
Figure 27. Europe Diagnostic Nuclear Drug Market Share by Application (2016-2027)
Figure 28. Europe Diagnostic Nuclear Drug Market Share by Country (2016-2027)
Figure 29. Germany Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diagnostic Nuclear Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Diagnostic Nuclear Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Diagnostic Nuclear Drug Market Share by Region (2016-2027)
Figure 39. China Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diagnostic Nuclear Drug Market Share by Type (2016-2027)
Figure 47. Latin America Diagnostic Nuclear Drug Market Share by Application (2016-2027)
Figure 48. Latin America Diagnostic Nuclear Drug Market Share by Country (2016-2027)
Figure 49. Mexico Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diagnostic Nuclear Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Diagnostic Nuclear Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Diagnostic Nuclear Drug Market Share by Country (2016-2027)
Figure 55. Turkey Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Diagnostic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bracco Imaging Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 59. Bayer Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 60. Curium Pharmaceuticals Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 61. Nordion Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 62. Triad Isotopes Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 63. Lantheus Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 64. GE Healthcare Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 65. China Isotope & Radiation Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 66. Jubilant Pharma Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 69. SIEMENS Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 70. Dongcheng Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 71. Navidea Revenue Growth Rate in Diagnostic Nuclear Drug Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の核医学治療薬市場規模・現状・予測（2021年-2027年）

Global Nuclear Drug for Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5899 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、核医学治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、主要地域別市場規模（北米...

世界の核医療治療薬市場規模・現状・予測（2021年-2027年）

Global Therapeutic Nuclear Drug Market Size, Status and Forecast 2021-2027
QFJ1-6035 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、核医療治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、主要地域別市場規模（北米...

世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2021-2027
QFJ1-3938 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、乳がん診断＆薬物技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マンモグラフィ、生検、その他）、用途別市場規模（乳管癌、浸潤性乳管癌、小葉癌、トリプルネガティブ乳がん）、主要地域別市場規模（北米、...

世界の抗核抗体（ANA）検査市場規模・現状・予測（2021年-2027年）

Global Anti-nuclear Antibody (ANA) Testing Market Size, Status and Forecast 2021-2027
QFJ1-5081 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、抗核抗体（ANA）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（間接蛍光抗体法、酵素免疫測定法（ELISA）、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界の抗核抗体検査市場規模・現状・予測（2021年-2027年）

Global Anti-Nuclear Antibody Test Market Size, Status and Forecast 2021-2027
QFJ1-3832 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、抗核抗体検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISA、間接蛍光抗体法、マルチプレックス試験）、用途別市場規模（全身性エリテマトーデス、シェーグレン症候群、関節リウマチ、強皮症、多発性...

世界の前立腺がん核医療診断市場規模・現状・予測（2021年-2027年）

Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-5968 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、前立腺がん核医療診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SPECT、PET）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の核融合＆先進材料市場規模・現状・予測（2021年-2027年）

Global Nuclear Fusion and Advanced Material Market Size, Status and Forecast 2021-2027
QFJ1-2388 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、核融合＆先進材料の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（重水素、トリチウム）、用途別市場規模（核融合パワー、道具細工、第4世代）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界の核医学アイソトープ市場規模・現状・予測（2021年-2027年）

Global Nuclear Medicine Isotopes Market Size, Status and Forecast 2021-2027
QFJ1-4598 2021年6月 129Pages
QYResearch社発行の本調査レポートでは、核医学アイソトープの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安定同位体、放射性同位元素）、用途別市場規模（核治療、機器放射線源、診断）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の核医学治療薬市場規模・現状・予測（2021年-2027年） Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capab…
世界の核医療治療薬市場規模・現状・予測（2021年-2027年） Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capab…
世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年） Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on. Market Analysis and Insights: Global Breast Cancer Diagnostic and Drug Technologies Market The global Breast Cancer Diagno…
世界の核融合＆先進材料市場規模・現状・予測（2021年-2027年） Nuclear fusion and advanced materials is the lastest technological advances in certain advanced materials Market Analysis and Insights: Global Nuclear Fusion and Advanced Material Market The global Nuclear Fusion and Advanced Material market size is projected to reach US$ XX million by 2027, from US…
世界の原子力発電市場規模・現状・予測（2021年-2027年） Nuclear power is a low-carbon source of electricity that plays a key role in the energy transition. It supports everyday electricity supply and the continued electrification of society with fossil free power. For decades to come long-term nuclear operations will continue to play an important role in…